IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato, Byoung Chul Cho, Masanobu Takahashi et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity

Qing Zhang, Jiacheng Bi, Xiaodong Zheng et al. · Nature Immunology · 2018 · 1.1K citations

Life Sciences, Immunology, Oncology +16

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

Émilie Mamessier, Aude Sylvain, Marie‐Laure Thibult et al. · Journal of Clinical Investigation · 2011 · 676 citations · Full text

Life Sciences, Immunology, Oncology +17

Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

Sophia Platonova, Julien Cherfils‐Vicini, Diane Damotte et al. · Cancer Research · 2011 · 483 citations

Life Sciences, Immunology, Oncology +17